cell-therapy

Documents about cell-therapy

• Development of Let's Get REAL: A Family Intervention for Pediatric Stem Cell Transplant and Cellular Therapy Decisions.#219099NCBI PubMed Central
• A circulating protein signature for predicting severe immune-related adverse events following CAR T-cell therapy in relapsed/refractory lymphoma#243510bioRxiv / medRxiv
• A cutting-edge solution to a Gordian knot? Aptamers targeting cancer stem cell markers for strategic cancer therapy#310092Universiti Putra Malaysia Institutional Repository
• Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma#321714ClinicalTrials.gov
• Association between comorbid depression, antidepressant adherence, and disease-modifying therapy adherence among Texas Medicaid patients with sickle cell disease.#327137NCBI PubMed Central
• Application and challenges of chimeric antigen receptor T cell therapy in the treatment of acute myeloid leukemia (Review).#330731NCBI PubMed Central
• Nocardia Cell Wall Skeleton for the Treatment of Diabetic Foot Ulcer Wounds#346872ClinicalTrials.gov
• Effect Of Radiotherapy Combined With Capsaicin And Fraxetin As Enhanced Therapy On Colorectal Cancer Cell Line In Vitro#356041USM Repository
• Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy#363612ClinicalTrials.gov
• Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers#383557ClinicalTrials.gov
• Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China#417529ClinicalTrials.gov
• Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer#424231ClinicalTrials.gov
• Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma#454033ClinicalTrials.gov
• A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC#460086ClinicalTrials.gov
• Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma#463707ClinicalTrials.gov
• Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML#471461ClinicalTrials.gov
• Single-cell and spatial omics of metabolic-immune ecosystems in prostate cancer: from androgen signaling to therapy resistance.#476919NCBI PubMed Central
• CTLA-4 and PD-1 Antibodies Expressing EGFR-CAR-T Cells for EGFR Positive Advanced Solid Tumor#481751ClinicalTrials.gov
• Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer#826464ClinicalTrials.gov
• Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy#837679ClinicalTrials.gov
• A Study for Identification of Predictive Immune Biomarker in Peripheral Blood for Nivolumab Therapy in NSCLC Patients#846562ClinicalTrials.gov
• Study Evaluating the Efficacy and Safety With CAR-T Immunotherapy for CD19 Positive Lymphoma#848458ClinicalTrials.gov
• Depletion of Myeloid Derived Suppressor Cells to Enhance Anti PD-1 Therapy#851939ClinicalTrials.gov
• Real-world Study of Local Therapy Changes During 1L Lorlatinib in Unresectable ALK+ NSCLC#852968ClinicalTrials.gov
• Dual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration#856369ClinicalTrials.gov
• Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme#865268ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma#807522ClinicalTrials.gov
• Monoclonal Antibody Therapy in Treating Patients With Recurrent or Refractory Lymphoma#803492ClinicalTrials.gov
• Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular Therapy.#140876NCBI PubMed Central
• A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML#803347ClinicalTrials.gov
• Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis#805704ClinicalTrials.gov
• Supplementary file 1_Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty.docx#361735Figshare
• Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma#424197ClinicalTrials.gov
• Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial#28299ClinicalTrials.gov
• Collection of autologous CD34+ hematopoietic progenitor cells (HPC) in multiple myeloma: CD34 + cell collection yield in relation to molecular subtype, karyotype, and FISH results#174819PLOS
• How to best exploit immunotherapeutics in advanced gastric cancer: between biomarkers and novel cell-based approaches#250634IRIS
• Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and Oteracil Potassium Capsules for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma#279517ClinicalTrials.gov
• Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line Therapy#429671ClinicalTrials.gov
• A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-CAR T Cells in the Treatment of Relapsed Refractory B-cell Non-Hodgkin Lymphoma#628547ClinicalTrials.gov
• Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC#806925ClinicalTrials.gov
• Epidemiology and care management of Paroxysmal Nocturnal Hemoglobinuria (PNH) in a real-world setting in France: Description from the French National Hospitalization Database#18905PLOS
• Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer#853344ClinicalTrials.gov
• The regulatory significance of chondrocyte hypertrophy in maintaining chondrocyte homeostasis, regeneration and repair#123332Europe PMC
• Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1#146480ClinicalTrials.gov
• Radiation-induced esophagitis and lung injury during esophageal squamous cell cancer therapy is correlated to tumor gene expression phenotype.#152200NCBI PubMed Central
• Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Cancer#217018ClinicalTrials.gov
• Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer#253066ClinicalTrials.gov
• Temporal regulation of G2 phase avoids therapy-induced senescence caused by DNA replication stress-inducing drugs and provides synergistic cytotoxicity#266274bioRxiv / medRxiv
• CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis#273159Europe PMC
• Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.#283027ClinicalTrials.gov